190 related articles for article (PubMed ID: 7872300)
21. The efficacy of portal vein embolization prior to right extended hemihepatectomy for hilar cholangiocellular carcinoma: a retrospective cohort study.
Hong YK; Choi SB; Lee KH; Park SW; Park YN; Choi JS; Lee WJ; Chung JB; Kim KS
Eur J Surg Oncol; 2011 Mar; 37(3):237-44. PubMed ID: 21227625
[TBL] [Abstract][Full Text] [Related]
22. Endoscopic management of hilar cholangiocarcinoma--one stent or two?
Hatfield AR
Bildgebung; 1995 Oct; 62 Suppl 2():53-4. PubMed ID: 8589585
[No Abstract] [Full Text] [Related]
23. Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarcinoma.
Nakagohri T; Asano T; Kinoshita H; Kenmochi T; Urashima T; Miura F; Ochiai T
World J Surg; 2003 Mar; 27(3):289-93. PubMed ID: 12607053
[TBL] [Abstract][Full Text] [Related]
24. Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes.
Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Kinoshita H
Hepatogastroenterology; 2002; 49(44):326-9. PubMed ID: 11995443
[TBL] [Abstract][Full Text] [Related]
25. [A long term survival case of advanced intrahepatic cholangiocarcinoma treated with multidisciplinary treatment].
Masuda T; Beppu T; Ishiko T; Mizumoto T; Hosaka S; Nakahara O; Hayashi H; Okabe H; Yamanaka T; Okabe K; Takamori H; Kanemitsu K; Hirota M; Baba H
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1944-6. PubMed ID: 17212154
[TBL] [Abstract][Full Text] [Related]
26. An intraductal papillary component is associated with prolonged survival after hepatic resection for intrahepatic cholangiocarcinoma.
Tajima Y; Kuroki T; Fukuda K; Tsuneoka N; Furui J; Kanematsu T
Br J Surg; 2004 Jan; 91(1):99-104. PubMed ID: 14716802
[TBL] [Abstract][Full Text] [Related]
27. Distal cholangiocarcinoma.
Liu K
J Surg Oncol; 2007 Mar; 95(3):192-3. PubMed ID: 17323332
[No Abstract] [Full Text] [Related]
28. Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma.
Uenishi T; Yamazaki O; Yamamoto T; Hirohashi K; Tanaka H; Tanaka S; Hai S; Kubo S
J Hepatobiliary Pancreat Surg; 2005; 12(6):479-83. PubMed ID: 16365823
[TBL] [Abstract][Full Text] [Related]
29. Cholangiocarcinoma metastatic to the neck: first report of a case.
Hardeman SH; Collins B; Lowe VJ; Solomon H; Stack BC
Ear Nose Throat J; 2002 Nov; 81(11):776-8. PubMed ID: 12472031
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological analysis of colorectal cancer liver metastasis and intrahepatic cholangiocarcinoma: are they just apples and oranges?
Chiu CT; Chiang JM; Yeh TS; Tseng JH; Chen TC; Jan YY; Chen MF
Dig Liver Dis; 2008 Sep; 40(9):749-54. PubMed ID: 18329969
[TBL] [Abstract][Full Text] [Related]
31. [Oncological surgery of the pancreas and bile ducts: current therapeutic prospects].
Silvestri A; Peparini N
G Chir; 2006; 27(11-12):401-4. PubMed ID: 17198547
[No Abstract] [Full Text] [Related]
32. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Zuo HQ; Yan LN; Zeng Y; Yang JY; Luo HZ; Liu JW; Zhou LX
Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):161-5. PubMed ID: 17374575
[TBL] [Abstract][Full Text] [Related]
33. Factors influencing survival after hepatectomy for peripheral cholangiocarcinoma.
Jan YY; Jeng LB; Hwang TL; Wang CS; Chen MF; Chen TJ
Hepatogastroenterology; 1996; 43(9):614-9. PubMed ID: 8799405
[TBL] [Abstract][Full Text] [Related]
34. Combined hepatocellular cholangiocarcinoma: prognostic factors investigated by computed tomography/magnetic resonance imaging.
Lin G; Toh CH; Wu RC; Ko SF; Ng SH; Chou WC; Tseng JH
Int J Clin Pract; 2008 Aug; 62(8):1199-205. PubMed ID: 17537192
[TBL] [Abstract][Full Text] [Related]
35. Molecular factors associated with recurrence and survival following hepatectomy in patients with intrahepatic cholangiocarcinoma: a guide to adjuvant clinical trials.
Schiffman SC; Nowacki MR; Spencer L; McMasters KM; Scoggins CR; Martin RC
J Surg Oncol; 2014 Feb; 109(2):98-103. PubMed ID: 24122302
[TBL] [Abstract][Full Text] [Related]
36. Clinical presentation and management of intrahepatic cholangiocarcinoma.
Farges O; Fuks D
Gastroenterol Clin Biol; 2010 Mar; 34(3):191-9. PubMed ID: 20202770
[No Abstract] [Full Text] [Related]
37. Long-term survival after curative left hepatectomy for mucin-producing cholangiocarcinoma: report of a case.
Tsuchikawa T; Kondo S; Hirano S; Tanaka E; Anbo Y; Morikawa T; Okushiba S; Otsuka N; Itoh T; Katoh H
Surg Today; 2005; 35(3):256-8. PubMed ID: 15772801
[TBL] [Abstract][Full Text] [Related]
38. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma.
Tamandl D; Herberger B; Gruenberger B; Puhalla H; Klinger M; Gruenberger T
Ann Surg Oncol; 2008 Oct; 15(10):2787-94. PubMed ID: 18685896
[TBL] [Abstract][Full Text] [Related]
39. Staging for intrahepatic cholangiocarcinoma.
Kokudo N; Arita J
Liver Int; 2010 Aug; 30(7):931-3. PubMed ID: 20408948
[No Abstract] [Full Text] [Related]
40. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
